Fig. 2
Comparison of PFS between the two groups of ESCC patients (C: Chemotherapy group, CC: Chemotherapy plus camrelizumab group)
Fig. 2 | World Journal of Surgical Oncology
Comparison of PFS between the two groups of ESCC patients (C: Chemotherapy group, CC: Chemotherapy plus camrelizumab group)